Literature DB >> 6452056

Drug-induced immune thrombocytopenia.

R A Moss.   

Abstract

A variety of drugs and other agents have been reported to cause immune-mediated platelet destruction. The cardinal features of this syndrome are acute, often alarming, purpura, closely related to drug exposure, which remits in one to two weeks after discontinuation of all suspect drugs. Quinidine and quinine have been most commonly implicated but, recently, both heparin and heroin have been the subject of numerous reports. Platelets are removed rapidly from the circulation, apparently as a result of the attachment of drug-antibody immune complexes. In vitro documentation of platelet injury by these complexes has inspired the development of many in vitro tests of differing sophistication. While valuable in confirming the clinical suspicion, none is sufficiently sensitive to exclude the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6452056     DOI: 10.1002/ajh.2830090412

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

Review 1.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

Review 2.  Principles of pharmacotherapy: IV. Hematologic drug reactions.

Authors:  T J Pallasch
Journal:  Anesth Prog       Date:  1989 Jan-Feb

3.  Immune thrombocytopenia associated with hemorrhagic diathesis due to ibuprofen administration.

Authors:  T Meyer; C Herrmann; V Wiegand; B Mathias; V Kiefel; C Mueller-Eckhardt
Journal:  Clin Investig       Date:  1993-05

4.  Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine.

Authors:  Lawrence C Ku; Huali Wu; Rachel G Greenberg; Kevin D Hill; Daniel Gonzalez; Christoph P Hornik; Alysha Berezny; Jeffrey T Guptill; Wenlei Jiang; Nan Zheng; Michael Cohen-Wolkowiez; Chiara Melloni
Journal:  Ther Drug Monit       Date:  2016-12       Impact factor: 3.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.